- Supplier site
- Group of sites (click to zoom)
Scientist.com supplier network (site locations)
Research supplier
Prime Global
Prime Global is listed as a mid sized business research supplier in the Scientist.com network, with 2 sites in 1 country.
View Prime Global on Scientist.com
Email me this page as a PDF
Sign in to Scientist.com to open this supplier in your organization's marketplace.
Search companies, drugs, suppliers and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Sites
2
Countries
1
Services
What this research supplier says it provides, as listed in the Scientist.com network.
Type of company: Mid sized business
Clinical Trials
- Prospective Explorative Studies Conduct a prospective exploratory study to assess the safety and efficacy of a test drug during clinical trials.
Creative
- Case Studies Recruit research participants with a behavioral condition to receive either an investigational behavioral intervention or a behavioral intervention in clinical use.
- Infographic Create a quick visual representation of information, data or knowledge.
- Product Marketing Bring a product to market.
HEOR
- Clinical Outcome Assessments (Non-Patient Reported) Measure a patient's symptoms, mental state and level of disease condition-related impact on daily life.
- Comparative Effectiveness The generation and synthesis of evidence that compares the benefits and harms of alternative methods to prevent, diagnose, treat, and monitor a clinical condition or to improve the delivery of care.
- Cost Benefit Analysis Economic evaluation in which costs and benefits (outcomes) are expressed in monetary units, to determine if the benefits of an intervention outweigh the costs.
- Cost Effectiveness Analysis Compare alternative treatments that lead to similar health outcomes.
- Decision Analytic Modeling Assess effects, costs and economic outcomes of treatment. These include cost-effectiveness models and budget impact models.
- Health Economics and Outcomes Research (HEOR) Evaluate data collected during drug development to maximize the value of a therapeutic product.
Show all 12 in HEOR
- HEOR Adherence Studies Strategy or study that assess extent to which patients or subjects follow recommendations for prescribed intervention; may include compliance assessment, as well as reasons related to actual or potential non-adherence.
- Patient Reported Outcomes (PRO) Assessment of health outcomes directly reported by the patient who experienced it, without interpretation of the patient's response by a clinician.
- Patient Treatment Patterns Assessment of treatment processes and patterns within clinical practice.
- Resource Utilization Descriptive and/or analytical review of a treatment that investigate the marketing, distribution, prescription, and use of drugs in populations. Endpoints to be assessed are the medical, social, and economic outcomes.
- Systematic Literature Review Summarizes the results of research (that meet pre-defined eligibility criteria for inclusion) and provides a high level of evidence on the outcomes assessed.
- Therapy Switch Insight into the reasoning of patients switching treatments and the outcomes of the switch.
Market Access
- Communication & Advertisement Distribution of a range of materials, through various communication channels, to highlight a message containing scientific-related topics
- Emerging Market Opportunities Analyze risks and opportunities in new markets and ensure patients have timely and continued access to new treatments.
- Formulary & Reimbursement Strategy Develop strategy and narrative to gain formulary access on insurance plans.
- Health Technology Assessment Submission (HTA Submission) Analyze the medical, social, ethical, humanistic, and economic considerations of a drug, medical device, or clinical procedures. Submissions are sent to regulatory agencies with different requirements that govern...
- Market Access Materials Find general strategies and methods used to market a pharmaceutical product or device.
- Market Research & Business Intelligence Run market feasibility studies, establish customer needs, improve product performance and analyze competition.
Show all 10 in Market Access
- Marketing and Commercialization Identify, promote and prove the value of a particular drug to key stakeholders.
- Pricing Strategy Develop value story tailored to a payer audience that will determine the appropriate price for treatment.
- Value Based Agreements or Outcomes-Based Contracts Collaborate with payer or provider to develop a reimbursement plan outside of the traditional fixed cost-per-unit that ties reimbursement or price to actual health outcomes.
- Value Dossiers Development Summary document that presents clinical, economic, and humanistic value of an intervention and associated disease state with the supporting evidence, formulated from the perspective of a particular stakeholder...
Show all 63 services
Medical Communications
- 1:1 KEE Engagement Management Compliant, individualized planning and documentation of scientific exchange meetings between Medical Science Liaisons (MSLs) and Key External Experts (KEEs).
- Abstracts Request services related to the writing and review of abstracts
- Creation of Non promotional Education/Awareness Content Development of scientifically rigorous, balanced materials (like disease state primers or journal clubs) aimed purely at enhancing clinical understanding, not driving product use.
- Distribution Strategy & Channel Recommendations Developing plans for how and where medical content (e.g., publications, training, MOA videos) will be efficiently delivered to the target healthcare audience.
- Mechanism of Disease (MOD) & Mechanism of Action (MOA) Videos Production of dynamic, scientifically accurate animated videos illustrating how a disease develops (MOD) and how a drug therapeutically affects the body (MOA).
- Medical Communications Master Class Design and execution of in-depth, high-level educational sessions led by top Key Opinion Leaders (KOLs) focusing on advanced clinical or scientific topics.
Show all 15 in Medical Communications
- Medical Education & Training Creation, development, production and dissemination (internally and externally) of non-promotional disease and treatment-related materials that educate specifically with medicine or healthcare.
- Medical Publications Make clear and accurate presentations of scientific and technical data.
- Medical Science Liaison (MSL) External Presentation Develop and design Medical Science Liaison External Presentations.
- Medical Science Liasion (MSL) Training Training for medical science liaisons who want to work in pharmaceutical, biotechnology, medical device, and managed care companies.
- Medical Website/Hub Design Design and maintenance of a compliant online portal serving as a repository for scientific publications, educational resources, and medical information for external stakeholders.
- Medical Writing and Editing/Manuscript Development Communicate scientific, technical and health-related information to a range of audiences.
- Poster Design and Development Design and Develop Posters for Poster Symposiums and conferences to effectively convey science information.
- Poster Symposia, Summits, Product Theaters, etc. Support Comprehensive planning and execution support for organized, large-scale medical meetings and events used to present and discuss clinical data and research.
- Target Product Profile (TPP) A sponsor prepared document which summarizes the drug development program that is described in terms of the labelling concepts. This profile is a communication method used between the FDA and sponsor which can be used...
Medical/Commercial
- Health & Pharmacoeconomics Identify, measure and compare the cost-benefit ratio of products and services.
- Life Cycle Assessment (LCA) Analyze the lifecycles of the products and services with regard to their environmental impacts.
Old Category HEOR, RWE, Market Access
- Non-Interventional Studies Examine different aspects of drug usage, including efficacy and safety, under real-life conditions.
- Patient-Reported Outcome Studies Get self-reported information regarding the personal health status of an individual.
Primary Market Research
- Persona Development Synthesizes qualitative and quantitative data to build detailed, actionable profiles of stakeholder archetypes. Supports targeted communications and segmentation strategies.
- Segmentation and Profiling Divides target audiences into distinct groups based on attitudes, behaviours, or demographics. Informs tailored messaging and targeting strategies.
Real World Evidence & Data
- Clinical Phenotype Data Obtain phenotypic data and observations on patients such as the clinical manifestation of the disease, clinical and behavioral parameters, symptoms, and laboratory test results.
- Meta-Analysis Use quantitative statistical approaches to pool results across multiple studies to improve power or resolve uncertainty; may be used in conjunction with a systematic review.
- Non-Comparative Study Assess an intervention using a single arm study design (without a control or comparator group).
- Patient Reported Outcomes (PRO) Databases Database or collection of data related to health outcomes directly reported by the patient who experienced it, without interpretation of the patient's response by a clinician or anyone else.
- Real World Evidence (RWE) Studies Studies (prospective or retrospective) utilizing data obtained from "real world settings" , and is outside the tight controls of a clinical trial design.
- Real-World Data Acquire real-world data from patients' electronic medical records including clinical information generated during the course of healthcare.
Show all 13 in Real World Evidence & Data
- Real-World Evidence Acquire clinical data from patients' medical records to analyze trends and the frequency of occurrence of different medical conditions.
- Registries - Disease Database containing, through utilizing observational research methods, standardized data about patients who have the same disease.
- Registries - Patient Database containing, through utilizing observational research methods, standardized data about patients who have the same condition, disease, or exposure and is used to evaluate an outcome
- Retrospective Exploratory Studies Retrospective exploratory studies
- RWD - Electronic Medical Record (EMR) Digital version of a patient's medical or health chart containing demographic, clinical, medical, and other treatment information.
- RWE/RWD Observational Research Research method for documenting clinical, economic, and or humanistic outcomes of actual medical practice absent the constraints of a more formal experimental design. See also Pragmatic Clinical Trials.
- Secondary Real World Evidence Analyze clinical trial data.
Regulatory Affairs
- Life Cycle Management Plan and strategy of the data collection and information throughout the different phases of product development (portfolio assessment, pre-clinical trials, clinical trials, pre-authorization, post-authorization, and RWE)
- Periodic Safety Update Report (PSUR) Preparation of safety reports to report adverse events that occurred during a specified time period. Evaluate if safety profile of treatment has changed since last report
- Post-authorization Safety Studies Research efforts conducted after a drug has been approved for market to monitor its safety profile in the general population. These studies aim to identify, characterize, or quantify potential adverse effects...
- Website
- primeglobalpeople.com
Where it operates
Sites by country, with the cities in each.
-
United Kingdom 2 sites
Work with Prime Global on Scientist.com
For prices, more details, or to contact Prime Global, visit Scientist.com.
Sign in to Scientist.com to open this supplier in your organization's marketplace.